NCT03887858View on ClinicalTrials.gov

"Study to Evaluate the Bioequivalence of Astellas Phama Korea Inc. Harnal-D in Healthy Volunteers"

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 11, 2019

Primary Completion Date

March 22, 2019

Study Completion Date

May 7, 2019

Conditions
Benign Prostatic Hyperplasia
Interventions
DRUG

Harnal-D Tab.

Harnal-D Tab. 1T single oral administration under fasting

DRUG

Chong Kun Dang Tamsulosin HCl Tab.

Chong Kun Dang Tamsulosin HCl Tab. 1T single oral administration under fasting condition

Trial Locations (1)

Unknown

Bestian Hospital, Osŏng

Sponsors
All Listed Sponsors
lead

Chong Kun Dang Pharmaceutical

INDUSTRY